The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
Filters: Collection: ehsl_novel_nam
1 - 25 of 3
| Title | Creator | Description | Identifier | ||
|---|---|---|---|---|---|
| 1 |
 |
Progressive Optic Atrophy in a Retinal Ganglion Cell-Specific Mouse Model of Complex I Deficiency (PDF) | Sidney M. Gospe, III, Luyu Wang, Mikael Klingeborn, Amanda Travis, Ying Hao, Vadim Arshavsky | Optic atrophy resulting from retinal ganglion cell (RGC) degeneration is the most prominent ocular manifestation of mitochondrial dysfunction. Efforts to develop effective pharmacotherapies for mitochondrial optic neuropathies have been hampered, in part, by the lack of an ideal preclinical animal m... | 20200310_nanos_sciplatform3_03-pdf |
| 2 |
 |
Progressive Optic Atrophy in a Retinal Ganglion Cell-Specific Mouse Model of Complex I Deficiency (Slides) | Sidney M. Gospe, III, Luyu Wang, Mikael Klingeborn, Amanda Travis, Ying Hao, Vadim Arshavsky | Optic atrophy resulting from retinal ganglion cell (RGC) degeneration is the most prominent ocular manifestation of mitochondrial dysfunction. Efforts to develop effective pharmacotherapies for mitochondrial optic neuropathies have been hampered, in part, by the lack of an ideal preclinical animal m... | 20200310_nanos_sciplatform3_03-slides |
| 3 |
 |
Progressive Optic Atrophy in a Retinal Ganglion Cell-Specific Mouse Model of Complex I Deficiency (Video) | Sidney M. Gospe, III, Luyu Wang, Mikael Klingeborn, Amanda Travis, Ying Hao, Vadim Arshavsky | Optic atrophy resulting from retinal ganglion cell (RGC) degeneration is the most prominent ocular manifestation of mitochondrial dysfunction. Efforts to develop effective pharmacotherapies for mitochondrial optic neuropathies have been hampered, in part, by the lack of an ideal preclinical animal m... | 20200310_nanos_sciplatform3_03 |
1 - 25 of 3